德菲洛克萨明皮肤内输送贴片用于治疗贝塔沙勒西米亚伤口
David Perrault1, Arhana Chattopadhyay1, Dharshan Sivaraj1,2
1From the Division of Plastic and Reconstructive Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA.
概括
局部使用的德费洛克萨 (DFO) 在首次对人体应用中成功治愈了慢性β-thalassemia伤口. 这种铁化疗法加速了愈合,为类似的不愈合的伤口提供了新的治疗途径.
科学领域:
- 血液学 血液学 血液学
- 伤口愈合 治愈 伤口愈合
- 皮肤病学 皮肤病学
背景情况:
- β-thalassemia是一种遗传性血液疾病,与慢性并发症有关,包括不愈合的伤口.
- 铁过载是β-thalassemia患者的常见问题,可能会损害伤口愈合.
- 在β-血病患者中,治疗慢性伤口的现有治疗方法已显示出有限的疗效.
研究的目的:
- 报告首次在人体上应用局部除胺 (DFO) 治疗β-血病患者的慢性不愈合的伤口.
- 在这种特定的临床背景下,评估局部DFO在促进伤口关闭方面的有效性.
主要方法:
- 一名患有β-血症和慢性不愈合的伤口的患者接受了局部用德费洛克萨 (DFO) 的治疗.
- 在21周的治疗期间,对伤口愈合的进展进行了监测.
- 处理涉及DFO的局部应用,利用其铁化特性.
主要成果:
- 患者的慢性不愈合的伤口在治疗前55周内略有改善,在21周的局部DFO应用后完全愈合.
- 这种治疗被患者耐受得很好.
- 观察到伤口愈合的显著加速.
结论:
- 局部用德胺 (DFO) 是一种有前途的治疗剂,可加速β-血病患者慢性伤口的愈合.
- 据信,DFO的铁化机制是其在促进伤口关闭方面的有效性的关键.
- 本案例研究支持进一步调查DFO作为一种新型治疗与β-thalassemia相关的伤口的新方法.
更多相关视频
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
1.9K
07:41Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
Published on: July 12, 2024
2.1K
相关概念视频
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...